COA 260441 matches MDx BioAnalytical Laboratory's public record. So this test doesn't rest on our review alone — the lab confirms it too.
260441This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
Label 30 mg · Lab measured 31.04 mg
103% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 7.8 mg using the measured mass, against 7.5 mg on the label — 3% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 260441 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 14 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | MDx BioAnalytical Laboratory's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of NA Selank Amidate from bioedgeresearchlabs.com, performed by MDx BioAnalytical Laboratory on January 28, 2026. Reported purity: 99.77%. Net content: 31.04 mg against 30 mg labeled (103% of label). Endotoxins: PASS (≤0.05 EU/mL). Batch 01192026SEL30. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 062026SEL30 | 3 Jul 2026 | Kovera Labs | 99.404% | 106% | ✓ Lab-verified |
| 062026SEL10 | 3 Jul 2026 | Kovera Labs | 99.786% | 102% | ✓ Lab-verified |
| 03312026SEL30 | 4 May 2026 | Kovera Labs | 99.934% | 106% | ✓ Lab-verified |
| 03312026SEL10 | 13 Apr 2026 | Kovera Labs | 99.939% | 114% | ✓ Lab-verified |
| 20260311SEL10 | 22 Mar 2026 | MDx BioAnalytical Laboratory | 99.76% | 101% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion